Wang Y X, Crofton J T, Share L
Department of Physiology and Biophysics, University of Tennessee, Memphis 38163, USA.
Am J Physiol. 1997 Jan;272(1 Pt 2):R370-6. doi: 10.1152/ajpregu.1997.272.1.R370.
The present study was carried out to investigate whether prostaglandins (PG) are involved in the mechanism that contributes to the sex difference in the antidiuretic and pressor actions of vasopressin. The experiments were performed in conscious male and nonestrous female rats. In hydrated rats, the graded infusion of vasopressin (10-1,000 pg.min 1.kg body wt-1) resulted in a dose-dependent antidiuresis: decreases in urine flow and free water clearance and an increase in urine osmolality. These responses were significantly greater in male than in nonestrous female rats. Pretreatment with a cyclooxygenase inhibitor, indomethacin (10 mg/kg body wt iv), significantly enhanced the antidiuretic response to vasopressin in both sexes. However, the magnitude of this enhancement was greater in female than in male rats. Thus indomethacin abolished the sex difference in the antidiuretic response to vasopressin. In a separate experiment in rats without water hydration and urine collection, infusion of pressor doses of vasopressin (1,000-6,000 pg.min-1.kg body wt-1) resulted in a greater increase in blood pressure in male than in nonestrous female rats. Treatment with indomethacin enhanced this response equivalently in both sexes and thus did not affect the sex difference in the pressor action of vasopressin. These data indicate that renal PG may mediate, at least in part, the sex difference in the antidiuretic action of vasopressin, whereas vascular PG seem not to play an important role in the sex difference in the pressor action of vasopressin.
本研究旨在探讨前列腺素(PG)是否参与了导致血管升压素抗利尿和升压作用性别差异的机制。实验在清醒的雄性和非发情期雌性大鼠中进行。在水合大鼠中,分级输注血管升压素(10 - 1000 pg·min⁻¹·kg体重⁻¹)导致剂量依赖性抗利尿作用:尿流量和自由水清除率降低,尿渗透压升高。这些反应在雄性大鼠中比在非发情期雌性大鼠中显著更大。用环氧化酶抑制剂吲哚美辛(10 mg/kg体重静脉注射)预处理,显著增强了两性对血管升压素的抗利尿反应。然而,这种增强的幅度在雌性大鼠中比在雄性大鼠中更大。因此,吲哚美辛消除了血管升压素抗利尿反应中的性别差异。在另一项不进行水合和尿液收集的大鼠实验中,输注升压剂量的血管升压素(1000 - 6000 pg·min⁻¹·kg体重⁻¹)导致雄性大鼠的血压升高幅度大于非发情期雌性大鼠。用吲哚美辛治疗在两性中同等程度地增强了这种反应,因此不影响血管升压素升压作用中的性别差异。这些数据表明,肾脏PG可能至少部分介导了血管升压素抗利尿作用中的性别差异,而血管PG似乎在血管升压素升压作用的性别差异中不发挥重要作用。